AI-ECG Platform vs PMcardio

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shenzhen Carewell Electronics Co., Ltd.
VS
by Powerful Medical

AI Verdict

Both tools offer AI-powered ECG analysis for diagnosing various cardiac conditions, making them direct competitors in the cardiology AI space. While Tool A emphasizes high accuracy in diagnosing major cardiovascular diseases and offers a workstation deployment, Tool B highlights its CE-certification, extensive clinical validation, and a freemium model with mobile app deployment and advanced features like AI explainability and culprit artery visualization.

Choose AI-ECG Platform if…

Choose the AI-ECG Platform if your healthcare facility requires a robust, hardware-independent AI solution for high-accuracy interpretation of 12-lead resting ECGs, particularly for diagnosing major cardiovascular diseases like arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. This platform is ideal for hospitals, clinics, and medical examination centers seeking to reduce the workload on professional ECG physicians and improve diagnostic efficiency with rapid analysis and comprehensive reporting features.

View AI-ECG Platform →

Choose PMcardio if…

Choose PMcardio if you need a highly portable, AI-powered ECG interpretation tool for rapid, expert-level assessment of over 50 cardiac conditions at the point of care, especially in emergency medicine, primary care, or pre-hospital settings. Its mobile app deployment, freemium pricing model, and features like STEMI/OMI detection with AI explainability make it suitable for individual clinicians, paramedics, and organizations aiming to improve diagnostic confidence and reduce treatment delays for time-critical cardiac events.

View PMcardio →

When choosing between the AI-ECG Platform by Shenzhen Carewell Electronics and PMcardio, physicians should consider their primary use case and deployment preferences. The AI-ECG Platform excels in providing a comprehensive, high-accuracy AI analysis and diagnosis system for 12-lead resting ECGs, with a strong focus on diagnosing major cardiovascular diseases like arrhythmias, ventricular hypertrophy, and myocardial ischemia. Its deployment options, including a workstation with GPU and a Windows-based diagnostic client, suggest suitability for established clinical environments requiring robust, integrated solutions for professional ECG review and report generation. The platform’s hardware independence and compatibility with various ECG machines offer flexibility for existing infrastructure.

In contrast, PMcardio offers a more agile and accessible AI platform, interpreting ECGs for over 50 cardiac conditions with a strong emphasis on point-of-care utility. Its deployment via mobile app, web platform, and enterprise integrations with EHR/CVIS and EMS systems makes it ideal for clinicians needing rapid, on-the-go interpretations. PMcardio’s freemium model and features like visual AI explainability with heatmaps (ECGxplain™) and culprit artery AI confidence scores with 3D heart visualization cater to users who value immediate insights and a more interactive diagnostic experience. The key practical difference lies in their deployment and accessibility: the AI-ECG Platform is geared towards a more centralized, in-depth diagnostic workflow, while PMcardio prioritizes rapid, distributed interpretation at the point of care.

Therefore, a physician seeking a robust, integrated system for detailed ECG analysis within a dedicated diagnostic setting might lean towards the AI-ECG Platform. Conversely, a physician or healthcare professional requiring quick, expert-level ECG interpretations across various settings, particularly those valuing mobile accessibility and immediate clinical decision support, would likely find PMcardio to be the more suitable choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Platform PMcardio
Pricing Contact for pricing Freemium
Deployment Workstation (with GPU), web-based portal, Windows-based diagnostic client Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers deployment via a mobile app (iOS and Android) and a web platform, which generally suggests higher accessibility and ease of use for individual clinicians at the point of care. AI-ECG Platform, while offering a web-based portal, also relies on a workstation with GPU and a Windows-based client, which might be less convenient for immediate use in diverse clinical settings. PMcardio's ability to digitize and improve the quality of ECGs from images, even distorted ones, further enhances its usability in real-world scenarios.

Clinical Value

PMcardio

PMcardio has been clinically validated in more than 25 independent, peer-reviewed studies and is trusted by over 100,000 clinicians. It detects over 50 cardiac conditions, including advanced features like 'Queen of Hearts' for STEMI/OMI detection and 'LVsense' for reduced LVEF detection, with visual AI explainability (ECGxplainu2122). While AI-ECG Platform boasts over 95% accuracy for major cardiovascular diseases and is FDA-cleared, the breadth of conditions detected and the extensive validation of PMcardio suggest a broader and more thoroughly proven clinical utility.

Pricing & Value

PMcardio

PMcardio offers a freemium model with 5 free ECG analyses per month, allowing users to experience the tool before committing to a paid plan. Its transparent pricing for individual and team plans is publicly available. AI-ECG Platform requires contacting for pricing, which offers less transparency and flexibility for individual users or smaller practices.

Enterprise Readiness

PMcardio

PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and provides 'PMcardio for Organizations' with custom pricing, unlimited users, and digital ECG integration (HL7, XML). It also explicitly states HIPAA compliance and has a BAA. AI-ECG Platform mentions a web-based management portal for organization settings and task management, and supports various ECG data formats, but PMcardio's explicit enterprise-focused offerings and integrations suggest a more robust enterprise readiness.

Innovation

PMcardio

PMcardio showcases significant innovation with features like 'Queen of Hearts' for Occlusion Myocardial Infarction (OMI) detection, 'LVsense' for reduced Left Ventricular Ejection Fraction (LVEF) detection, and 'ECGxplain' for visual AI explainability with heatmaps. These features go beyond basic ECG interpretation by offering deeper insights and transparency into the AI's decision-making. While AI-ECG Platform offers rapid and accurate analysis, PMcardio's specific, advanced AI modules and explainability features demonstrate a higher degree of innovation in the field.

Support & Docs

Tie

Both tools provide general information about their capabilities. PMcardio offers a Help Center, FAQ, and email support, along with resources like a blog, regulatory information, and security details. AI-ECG Platform's documentation and support specifics are not as readily available in the provided information or public web searches. However, without direct comparative details on the quality and comprehensiveness of support and documentation for AI-ECG Platform, it is difficult to definitively declare a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Platform PMcardio
Name AI-ECG Platform PMcardio
Company Shenzhen Carewell Electronics Co., Ltd. Powerful Medical
Tagline AI-Powered Analysis System for ECG AI that reads ECGs in seconds
Key Features (Analysis/Diagnosis) AI-powered automatic ECG analysis and diagnosis, diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction, over 95% accuracy in diagnosing major cardiovascular diseases Instant AI-powered ECG interpretations, detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies)
Hardware Independence/Compatibility Hardware independent, compatible with most ECG machines Not specified
Data Formats Supported Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG Not specified
AI Explainability Not specified ECGxplainu2122 - Visual AI Explainability with heatmaps

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Platform and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Platform supports various ECG data formats like Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, and MFER ECG, suggesting compatibility with different systems. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, aiming to fit into existing workflows by capturing inputs, running relevant AI for clinical context, and coordinating downstream actions.
The AI-ECG Platform boasts over 95% accuracy in diagnosing major cardiovascular diseases, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. PMcardio has been clinically validated in over 25 studies and claims 2x higher sensitivity for early STEMI detection and 98.3% accuracy for atrial fibrillation. One study showed PMcardio had 86% sensitivity and 92% specificity for major ECG abnormalities, and for AF, sensitivity and specificity were 97% and 99% respectively.
PMcardio aims to ease the learning curve with a brief guide for digitizing ECGs, emphasizing two simple rules: matching the ECG pictogram to the recording layout and ensuring horizontal positioning of leads. The presence of AI explainability features like ECGxplainu2122 with heatmaps in PMcardio can also aid in understanding the AI's decisions, potentially reducing the learning curve and building trust.
The AI-ECG Platform provides AI-powered automatic ECG analysis and diagnosis, offering rapid diagnosis in approximately 3 seconds. PMcardio offers detection of over 50 cardiac conditions, including STEMI/OMI, reduced LVEF, and conduction disorders, along with visual AI explainability (ECGxplainu2122) and Culprit Artery AI confidence scores with 3D heart visualization. PMcardio also generates patient management recommendations based on ESC guidelines, including specific therapeutic strategies, procedures, and drugs.
PMcardio for Organizations includes full audit trails, allowing for tracking of pathway performance across sites and teams, and supporting QA, audits, and protocol optimization. The detailed ECG report history in PMcardio also allows for revisiting and exporting past analyses for documentation and audits.
PMcardio for Organizations is designed for enterprise-ready deployment, connecting to existing systems and scaling across campuses and care settings without custom builds. It aims to unify AI-powered detection, decision support, and care coordination across various cardiac pathways, standardizing diagnostic accuracy across entire health systems.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.